All In Biotech

Drug Trial Radar · NCT07308938

Fluorometholone Study

Trial of Topical Fluorometholone as Adjunctive Therapy for Bacterial Corneal Ulcers

Last checked: Nov 19, 2026Latest source record: Jun 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 174 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

174

Planned (sponsor's estimate)

Start

Oct 31, 2026

Primary completion

Dec 31, 2029

Study completion Dec 31, 2030

Sponsor

Lead sponsor
Vishal JhanjiAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Pittsburgh Medical Center
First posted
Dec 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.

Conditions

  • Keratitis Bacterial
  • Corneal Ulcer (Diagnosis)

Interventions

  • Adjunctive Topical Fluorometholone (FML) 0.1%Drug

    Adjunctive Topical Fluorometholone (FML) 0.1% will be used

  • Standard Topical Antibiotic TherapyDrug

    Patients will be treated with antibiotics (Cefazolin, Tobramycin or Moxifloxacin) we per treating physician

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Best Corrected Visual Acuity (BCVA)Time frame: From enrollment to 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UPMC Vision Institute

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.